CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens - Investing.com Canada

Source: Investing.com Canada · 2026-09-28T09:24:13+00:00

CRISPR Therapeutics stock price target reaffirmed at $80 by Citizens Investing.com Canada

BestAIBroker analysis

Finance-aware sentiment: slightly positive (+0.10 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 28/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: ACRS, CAPR, CCCC, ACRV, COEPW.